Company Filing History:
Years Active: 2016
Title: Didier Nourrisson: Innovator in Sustained-Release Drug Composition
Introduction
Didier Nourrisson is a notable inventor based in Vernouillet, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug compositions that enhance the efficacy of peptide-based treatments.
Latest Patents
Nourrisson holds a patent for a sustained-release composition containing peptides as the active ingredient. This innovative drug composition consists primarily of microparticles of a peptide, which acts as the active substance, combined with a biocompatible water-soluble polymer. The invention also includes an injection formulation that suspends the sustained-release drug composition in an injection medium. This advancement has the potential to improve the delivery and effectiveness of peptide therapies.
Career Highlights
Didier Nourrisson is associated with Ipsen Pharma S.a.s., a company known for its focus on innovative medicines. His work at Ipsen Pharma has allowed him to contribute to the development of cutting-edge pharmaceutical solutions that address various medical needs.
Collaborations
Nourrisson has collaborated with talented professionals in his field, including Joël Richard and Faïza Laredj. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Didier Nourrisson's work in sustained-release drug compositions exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions continue to pave the way for advancements in peptide-based therapies.